PTC Therapeutics
PTCT
PTCT
148 hedge funds and large institutions have $1.15B invested in PTC Therapeutics in 2018 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 40 increasing their positions, 45 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
10.26% more ownership
Funds ownership: 91.86% → 102.12% (+10%)
10% less call options, than puts
Call options by funds: $24.3M | Put options by funds: $27.1M
11% less repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 45
Holders
148
Holding in Top 10
7
Calls
$24.3M
Puts
$27.1M
Top Buyers
| 1 | +$47.9M | |
| 2 | +$22.9M | |
| 3 | +$17.9M | |
| 4 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
+$14.5M |
| 5 |
Morgan Stanley
New York
|
+$13M |
Top Sellers
| 1 | -$15.2M | |
| 2 | -$14.2M | |
| 3 | -$10.9M | |
| 4 |
Parallax Volatility Advisers
San Francisco,
California
|
-$10.6M |
| 5 |
SIM
Spark Investment Management
New York
|
-$10.3M |